Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-10-20

Clinical Trial Update: Safety and Efficacy Study of Fibrin Sealant (FS 4IU) for Skin Graft Fixation and Wound Healing in Subjects With Burn Wounds [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trials evaluated the safety and efficacy of Fibrin Sealant FS 4IU for fixing skin grafts and promoting wound healing in burn patients. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fibrin Sealant FS 4IU (fibrin sealant)

Snippet

Sponsor: Baxter Healthcare Corporation | Conditions: Burns | Phase 1, Phase 2 | Status: COMPLETED